NEUROBLOOD
DEAD

Serial Number

79209626

Owner

M. romain verpillot

Filing Date

Mar 15, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NEUROBLOOD Trademark

Serial Number: 79209626

NEUROBLOOD is a trademark filed by M. romain verpillot on March 15, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

M. romain verpillot

Incuballiance, 86 rue de Paris

Entity Type: 01

Trademark Details

Filing Date

March 15, 2017

Registration Date

Not Registered

Goods & Services

Scientific apparatus and analytical instruments namely, instruments dedicated to separation of biomolecules such as High Performance Liquid Chromatography, Electrophoresis, Capillary Electrophoresis, Mass Spectrometry, Infrared Spectrometry, RAMAN Spectrometry, spectroscopy, DNA-Sequencer , RNA-Sequencer, Lab on chip, DNA-microarray, RNA-microarray; Measuring apparatus and instruments used for measuring biomarkers in biological liquids, blood samples such as free or labelled monoamines, derivates of monoamines, Red-Ox forms of monoamines subsequently detected by Laser induced fluorescence detection or Electrochemical detection; signaling apparatus and instruments namely such as High Performance Liquid Chromatography, Electrophoresis, Capillary Electrophoresis, Mass Spectrometry, Infrared Spectrometry, RAMAN Spectrometry, spectroscopy, DNA-Sequencer , RNA-Sequencer, lab on chip, DNA-microarray, RNA-microarray; software screening, monitoring, revealing of mental illnesses, including learning disabilities and Alzheimer's disease, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy, other neurodegenerative diseases, and aggregating, analyzing, and reporting of blood tests results; detectors namely, Electrochemical, spectrometry spectroscopy, diode array, photo multiplicator

Pharmaceutical preparations for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases; veterinary preparations of prevention and monitoring of neurodegenerative illnesses in animal models, namely dogs, cats, mice, rats, monkeys; sanitary preparations for medical purposes use for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases; chemical preparations for medical use for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases; chemical preparations for pharmaceutical use for the prevention of Alzheimer, Parkinson diseases, amyotrophic lateral sclerosis, frontotemporal dementia, progressive supranuclear palsy and other neurodegenerative diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 12, 2019 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jun 24, 2019 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 24, 2019 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 30, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 14, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 14, 2018 OPNR
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Jun 25, 2018 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Jun 24, 2018 ABN0
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Jan 5, 2018 NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Jan 4, 2018 NAUD
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2017 TROA
REFUSAL PROCESSED BY IB
Jul 14, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 28, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jun 28, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 20, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jun 19, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 16, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 12, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 8, 2017 REPR